PubRank

M Clementi

Author PubWeight™ 155.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 1992 3.48
2 Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995 2.75
3 Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996 2.41
4 Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol 2012 2.38
5 Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG 2012 2.14
6 High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology 1999 2.12
7 Evaluation of prenatal ultrasound diagnosis of fetal abdominal wall defects by 19 European registries. Ultrasound Obstet Gynecol 2001 2.10
8 Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med 1997 1.92
9 Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol 1992 1.85
10 Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol 1992 1.80
11 Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology 2007 1.61
12 Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet 2001 1.61
13 Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1999 1.50
14 Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 2009 1.49
15 Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries. Eur J Med Genet 2005 1.45
16 How wide is the clinical spectrum of the acrocallosal syndrome? Report of a mild case. J Med Genet 1990 1.44
17 Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood 1997 1.41
18 Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet 2000 1.38
19 Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet 1999 1.32
20 Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 1997 1.32
21 Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol 1996 1.27
22 Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. J Med Virol 1991 1.26
23 Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001 1.25
24 Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet 2004 1.25
25 Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 1998 1.21
26 Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol 2001 1.19
27 Evaluation of the prenatal diagnosis of limb reduction deficiencies. EUROSCAN Study Group. Prenat Diagn 2000 1.17
28 Adverse effects of prenatal methimazole exposure. Teratology 2001 1.17
29 Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J Clin Microbiol 1995 1.16
30 Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 1997 1.15
31 Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol 1998 1.13
32 Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat 1999 1.13
33 Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol 1994 1.12
34 Omphalocele and gastroschisis: a collaborative study of five Italian congenital malformation registries. Teratology 1993 1.11
35 NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet 2000 1.09
36 Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Virology 2001 1.08
37 Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology 1993 1.04
38 Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol 1994 1.04
39 Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. J Virol 1999 1.04
40 Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen 2000 1.03
41 Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. Hum Genet 2001 1.03
42 Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. Virology 1999 1.03
43 A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology 1997 1.02
44 Congenital diaphragmatic hernia: evaluation of prenatal diagnosis in 20 European regions. Ultrasound Obstet Gynecol 2002 1.02
45 Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol 1994 1.02
46 The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005 1.02
47 Ionizing radiations in pregnancy and teratogenesis: a review of literature. Reprod Toxicol 2005 1.02
48 Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 1999 1.01
49 Schwartz-Jampel syndrome type 2 and Stüve-Wiedemann syndrome: a case for "lumping". Am J Med Genet 1998 1.01
50 CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996 1.00
51 Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection. J Virol 2000 1.00
52 ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion. Neurology 2011 0.99
53 Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet 2013 0.98
54 An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene. Am J Kidney Dis 1996 0.96
55 Contribution of ultrasonographic examination to the prenatal detection of chromosomal abnormalities in 19 centres across Europe. Ann Genet 2001 0.95
56 Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors. Res Virol 1997 0.94
57 Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C. Liver 1999 0.93
58 Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. Virology 1992 0.92
59 Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway. Br J Cancer 2007 0.91
60 Anophthalmia and benomyl in Italy: a multicenter study based on 940,615 newborns. Reprod Toxicol 1995 0.91
61 Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol Cell Probes 1994 0.91
62 Clearance of HIV-1 viraemia after seroconversion. Lancet 1993 0.91
63 Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand 1988 0.90
64 Turner syndrome: evaluation of prenatal diagnosis in 19 European registries. Am J Med Genet A 2004 0.90
65 A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. J Virol Methods 1991 0.89
66 D8S7 is consistently deleted in inverted duplications of the short arm of chromosome 8 (inv dup 8p). Hum Genet 1993 0.89
67 Transmission of hepatitis C virus in a gynecological surgery setting. J Clin Microbiol 2001 0.89
68 Prenatal detection of rare chromosomal autosomal abnormalities in Europe. Am J Med Genet A 2003 0.89
69 Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients. Clin Diagn Lab Immunol 1994 0.89
70 Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol 2000 0.88
71 An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics. N Engl J Med 1986 0.88
72 Evaluation of prenatal diagnosis of associated congenital heart diseases by fetal ultrasonographic examination in Europe. Prenat Diagn 2001 0.88
73 Theoretical recurrence risks for cleft lip derived from a population of consecutive newborns. J Med Genet 1988 0.88
74 Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. J Virol 2001 0.88
75 Phylogenetic internal control for HIV-1 genotypic antiretroviral testing. New Microbiol 2004 0.86
76 Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. New Microbiol 2004 0.86
77 Cardiovascular anomaly in Rieger Syndrome: heterogeneity or contiguity? Acta Ophthalmol Scand 1998 0.86
78 Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. J Virol Methods 1991 0.86
79 Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? J Hepatol 1998 0.85
80 Antibody response to individual cytomegalovirus structural proteins in different groups of subjects. Eur J Clin Microbiol 1987 0.85
81 The Euroscan study. Ultrasound Obstet Gynecol 2001 0.85
82 Another Italian family with mandibuloacral dysplasia: why does it seem more frequent in Italy? Am J Med Genet 1986 0.85
83 Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption. Clin Microbiol Infect 2010 0.85
84 Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure. J Acquir Immune Defic Syndr 2000 0.84
85 Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. J Biol Regul Homeost Agents 2003 0.84
86 Heritability of myopic refractive errors in identical and fraternal twins. Graefes Arch Clin Exp Ophthalmol 1993 0.84
87 Humoral immune response against hepatitis C virus. J Biol Regul Homeost Agents 2003 0.84
88 Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. AIDS 1998 0.84
89 Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up. Clin Microbiol Infect 2013 0.83
90 Detection of HBV infectivity by spot hybridization in HBeAg-negative chronic carriers: HBV DNA in sera from asymptomatic and symptomatic subjects. J Med Virol 1987 0.83
91 Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia. Clin Exp Immunol 1996 0.83
92 Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus. J Clin Pathol 1994 0.83
93 Psittacosis of non-avian origin. Lancet 1984 0.82
94 Diagnosis of human rotavirus infections: comparison of an electrophoretic method, a modified complement fixation test and electron microscopy for rotavirus detection. Arch Virol 1981 0.82
95 Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL. AIDS Res Hum Retroviruses 1997 0.82
96 Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. Virology 2001 0.82
97 Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus. J Biol Regul Homeost Agents 2003 0.82
98 Pachyonychia congenita Jackson-Lawler type: a distinct malformation syndrome. Br J Dermatol 1986 0.82
99 Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. AIDS Res Hum Retroviruses 1997 0.81
100 Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy. Antivir Ther 1997 0.81
101 Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clin Exp Immunol 1998 0.81
102 HCV infection by cell-to-cell transmission: choice or necessity? Curr Mol Med 2012 0.81
103 Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand 2000 0.81
104 Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis. J Hepatol 1997 0.81
105 Lack of Chlamydia infection of the central nervous system in multiple sclerosis. Ann Neurol 2000 0.81
106 A vector for the expression of recombinant monoclonal Fab fragments in bacteria. J Immunol Methods 1998 0.81
107 Prenatal diagnosis of dysmorphic syndromes by routine fetal ultrasound examination across Europe. Ultrasound Obstet Gynecol 2003 0.81
108 A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. Antivir Ther 1999 0.81
109 SPINK3 modulates mouse sperm physiology through the reduction of nitric oxide level independently of its trypsin inhibitory activity. Reproduction 2012 0.81
110 Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment. J Hepatol 1997 0.81
111 Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis. J Hepatol 1996 0.81
112 Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial. Eur J Surg Oncol 2006 0.80
113 Low-amplitude propagated contractile waves: a relevant propulsive mechanism of human colon. Dig Liver Dis 2001 0.80
114 Microphthalmia-congenital anterior polar cataract. An autosomal dominant syndrome. Ophthalmic Paediatr Genet 1985 0.80
115 Chorio-retinal dysplasia, microcephaly and mental retardation. An autosomal dominant syndrome. Clin Genet 1981 0.80
116 CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. Eur J Neurol 2012 0.80
117 Chorioretinal coloboma and Joubert syndrome: a nonrandom association. J Pediatr 1984 0.80
118 Detection of hepatitis B virus DNA in serum using synthetic non-radioactive oligonucleotides. J Clin Pathol 1989 0.79
119 Characterization of GBV-C infection in HIV-1 infected patients. J Biol Regul Homeost Agents 2003 0.79
120 An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries. Res Virol 1997 0.79
121 Adenoma-carcinoma sequence of colorectum. Prevalence of K-ras gene mutation in adenomas with increasing degree of dysplasia and aneuploidy. Diagn Mol Pathol 1995 0.79
122 Popliteal pterygium syndrome presenting with orofacial abnormalities. Report of a family. J Maxillofac Surg 1984 0.79
123 Differential effect of stress on gastric somatostatin, prostaglandin E and gastrin release in the rat. Ital J Gastroenterol Hepatol 1997 0.79
124 Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis 2012 0.79
125 Molecular epidemiology of TT virus in Italy and phylogenesis of viral isolates from subjects at different risk for parenteral exposure. J Med Virol 2001 0.79
126 Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. Infection 2013 0.79
127 "Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3. Eur J Gynaecol Oncol 2012 0.79
128 Viral load in samples from hepatitis C virus (HCV)-infected patients with various clinical conditions. Res Virol 1996 0.79
129 Growth-factor independence of a new differentiated hepatitis B virus DNA-negative human hepatoma cell line. Hepatology 1990 0.79
130 Thoracic stop-flow perfusion in the treatment of refractory non small cell lung cancer. J Chemother 2004 0.78
131 Topic: Abdominal Wall Hernia - Abdominal wall closure. Hernia 2015 0.78
132 Complexity and dynamics of HIV-1 quasispecies. J Biol Regul Homeost Agents 2000 0.78
133 Coeliac disease associated with peripheral neuropathy in a child: a case report. Neuropediatrics 1998 0.78
134 Clinical pattern of adult polycystic kidney disease in a northeastern region of Italy. Clin Nephrol 2009 0.78
135 Psittacosis in a highly endemic area in Italy. Epidemiol Infect 1987 0.78
136 Perspectives and opportunities for novel antiviral treatments targeting virus fitness. Clin Microbiol Infect 2008 0.78
137 Hepatitis C virus infection and mixed cryoglobulinaemia: assessment of HCV RNA copy numbers in supernatant, cryoprecipitate and non-liver cells. J Viral Hepat 1996 0.78
138 Autosomal dominant benign recurrent intrahepatic cholestasis (BRIC) unlinked to 18q21 and 2q24. Am J Med Genet 2000 0.77
139 Sexual transmission of hepatitis C virus and prevention with intramuscular immunoglobulin. AIDS Patient Care STDS 1998 0.77
140 [Meningitis caused by Echovirus 25]. Minerva Med 1978 0.77
141 Chemometric methodologies in a quantitative structure-activity relationship study: the antibacterial activity of 6-aminoquinolones. J Med Chem 1997 0.77
142 Dynamics of hepatitis C viremia after plasma exchange. J Hepatol 1999 0.77
143 Contribution of ultrasonographic examination to the prenatal detection of trisomy 21: experience from 19 European registers. Ann Genet 2004 0.77
144 Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen. Hum Immunol 2001 0.77
145 Mutation producing alternative splicing of exon 26 in the COL1A2 gene causes type IV osteogenesis imperfecta with intrafamilial clinical variability. Am J Med Genet 1997 0.77
146 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis. J Med Chem 1999 0.77
147 Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates. Transfus Med 2005 0.77
148 Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients. Arch Virol 1997 0.76
149 Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange. J Infect Dis 1997 0.76
150 A new disease-causing mutation in the GAP-related domain of the NF1 gene. Hum Mol Genet 1993 0.76
151 Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC. Eur J Hum Genet 2000 0.76
152 Differential response of the human hepatoma-derived cell line HA22T/VGH to polypeptide mitogens. FEBS Lett 1987 0.76
153 Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy. AIDS 1998 0.76
154 Dynamics of viral quasispecies in hepatitis C virus infection. Res Virol 1997 0.75
155 Amniotic band sequence in child of thalidomide victim. BMJ 1994 0.75
156 Quantitative techniques and HIV-1 load in plasma and semen. AIDS 1998 0.75
157 Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications. BJOG 2013 0.75
158 Growth and metabolic responses in low-birth-weight infants fed human milk fortified with human milk protein or with a bovine milk protein preparation. J Pediatr Gastroenterol Nutr 1991 0.75
159 Rhodococcus equi pneumonia in a patient with occult HIV infection: successful therapy. Panminerva Med 1997 0.75
160 Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism. Clin Genet 2013 0.75
161 Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. New Microbiol 2004 0.75
162 External physical examination of stillborns. Hum Pathol 1984 0.75
163 Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases. J Hepatol 2001 0.75
164 Human growth hormone induced modulation of hepatitis B virus (HBV) gene expression. Dev Biol Stand 1987 0.75
165 Viral dynamics and mutations in the pol gene during primary HIV-1 infection. J Biol Regul Homeost Agents 2000 0.75
166 Double-blind manometric assessment of two topical glyceryl trinitrate formulations in patients with chronic anal fissures. Dig Liver Dis 2000 0.75
167 Quantitation of HIV-1 genome copy number in semen and saliva. AIDS 1995 0.75
168 TOFE human-B-cell-line-based adsorption-inhibition assay to detect HCV neutralizing antibodies. Res Virol 1999 0.75
169 [Rotavirus infections in the province of Ancona. Sero-epidemiological studies]. Ann Sclavo 1981 0.75
170 Autosomal dominant microcephaly. J Pediatr 1983 0.75
171 [Pandemic influenza: rapid sanitary-hygienic measures for initial containment of diffusion]. Ann Ig 2008 0.75
172 Complement-fixation test for rotavirus detection: comparison and analysis of different methods to reduce anti-complementary activity of some specimens. J Virol Methods 1982 0.75
173 [Magnetic resonance angiography of the intracranial circle using magnetization transfer contrast (MTC)]. Radiol Med 1995 0.75
174 Insulin reduces HBsAg production by PLC/PRF/5 human hepatoma cell line. Brief report. Arch Virol 1984 0.75
175 Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisal. BioDrugs 1999 0.75
176 [Preventive measures suggested to protect health workers from the risk due to a potential exposure to SARS agents]. Ann Ig 2004 0.75
177 Effect of phenolic and chlorine disinfectants on hepatitis C virus binding and infectivity. Am J Infect Control 1999 0.75
178 [Registry of congenital malformation. Performing the follow-up]. Pathologica 1988 0.75
179 Lack of detectable human T-cell lymphotropic virus type I sequences in samples from multiple sclerosis patients. J Med Virol 1992 0.75
180 [Pulmonitis caused by Coxiella burneti and Chlamydia psittaci. 2 years of research in Marche]. Boll Ist Sieroter Milan 1984 0.75
181 [Analysis of disaccharidase activity of the amniotic fluid for the early prenatal diagnosis of abnormalities of patency and motility of the fetal intestine]. Minerva Ginecol 1985 0.75
182 The introduction of the fusion inhibitors in the HAART-regimens. New Microbiol 2004 0.75
183 Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques. Gynecol Obstet Invest 1994 0.75
184 Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon. J Viral Hepat 1995 0.75
185 5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. Ital J Gastroenterol Hepatol 1998 0.75
186 [Animal experimentation in radiology. Objectives, organizational and ethical problems]. Radiol Med 1993 0.75
187 Quantitation of hepatitis C virus RNA production in two human bone marrow-derived B-cell lines infected in vitro. Res Virol 1997 0.75
188 766 cases of oral cleft in Italy. Data from Emilia Romagna (IMER) and northeast Italy (NEI) registers. Eur J Epidemiol 1994 0.75
189 Carcinoma of the duodenum: management and survival in 14 cases. Panminerva Med 1997 0.75
190 A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression. Dev Biol Stand 1985 0.75
191 [Pancreatic assessment by magnetic resonance imaging: an improvement in the diagnostic results with new study technics]. Radiol Med 1995 0.75
192 Modulation of production of hepatitis B surface antigen by a human hepatoma cell line. J Med Virol 1984 0.75
193 Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Haemophilia 1997 0.75
194 Humoral immune response and natural killer activity in patients with mixed cryoglobulinemia. Clin Exp Rheumatol 1996 0.75
195 Direct detection of HBV preC mutants in heterogeneous viral populations by a modified DNA sequencing method. Res Virol 1993 0.75
196 [Re-alimentation of infants with acute gastroenteritis. Effectiveness of the type of milk]. Minerva Pediatr 1979 0.75
197 [Seroepidemiology of infection by hepatitis B virus in student nurses: some implications for vaccination policy]. Boll Ist Sieroter Milan 1985 0.75
198 [Epidemiologic study on the distribution of rubella antibodies in the female population of the Marches]. Minerva Med 1979 0.75
199 [Antisepsis and disinfection in emerging and re-emerging viral diseases]. Ann Ig 2006 0.75
200 Transient blocking coagulation inhibitor in a 18-month-old boy. Folia Haematol Int Mag Klin Morphol Blutforsch 1982 0.75
201 Levels of pre-S antigens and HBV DNA in sera from high and low viremic HBV carriers. J Med Virol 1991 0.75
202 Body size and early growth in appropriate- and large-for-gestational-age infants. Acta Paediatr 2003 0.75
203 [Adaptation to defined chemical conditions of the in vitro growth of PLC/PRF/5 cells]. Boll Soc Ital Biol Sper 1985 0.75
204 [Prenatal diagnosis of congenital defects of the abdominal wall]. Minerva Ginecol 1986 0.75
205 Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line. Dev Biol Stand 1985 0.75
206 A human hepatoma cell line modulates its insulin receptors under different culture conditions. Boll Soc Ital Biol Sper 1985 0.75
207 Anesthesiologic problems in Williams syndrome: the CACNL2A locus is not involved. Hum Genet 1996 0.75
208 Lethal multiple pterygium syndrome: importance of fetal physical examination. Am J Med Genet 1995 0.75
209 [Atresia of the extrahepatic bile ducts. A problem more than surgical]. Minerva Pediatr 1982 0.75
210 Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests. Neurology 2005 0.75
211 Serum-free growth of human hepatoma cells. A review. Adv Biochem Eng Biotechnol 1987 0.75
212 Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. J Infect Dis 1999 0.75
213 [Hepatocarcinoma cell lines in vitro: binding of insulin]. Boll Soc Ital Biol Sper 1987 0.75
214 Co-amplification of transcriptionally active epidermal growth factor receptor and ribosomal genes in the human hepatoma cell line Li7A. Oncogene 1992 0.75
215 Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. AIDS 2000 0.75
216 Hepatitis C virus infection of a Vero cell clone displaying efficient virus-cell binding. Res Virol 1997 0.75
217 [Surfactant and ambroxol in the therapy of idiopathic respiratory syndrome in newborn infants]. Minerva Pediatr 1991 0.75
218 Characterization of growth parameters of a human hepatoma cell line cultured under serum-free conditions. Ric Clin Lab 1985 0.75
219 [A focus of pneumonia caused by Mycoplasma pneumoniae in the province of Ancona]. Minerva Med 1979 0.75
220 Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line. Ric Clin Lab 1987 0.75
221 [Cross-over electrophoresis on cellulose acetate. A new method for rapid diagnosis of rotavirus infection]. Boll Ist Sieroter Milan 1980 0.75
222 [A small epidemic focus of pulmonitis caused by Legionella]. Minerva Med 1985 0.75
223 Induced underglycosylation of PLC/PRF/5 human hepatoma cells. Brief report. Arch Virol 1983 0.75
224 [Multiple calcifications of the intervertebral disks and other unusual anomalies in a neonatal case report of trisomy 13 syndrome (Patau's disease)]. Radiol Med 1988 0.75
225 [Epidemiology of psittacosis in an area of the Marche region]. Nuovi Ann Ig Microbiol 1985 0.75
226 [Respiratory tract infections caused by viruses, Mycoplasma, Rickettsia and Chlamydia with bronchial and pulmonary localization]. Minerva Med 1984 0.75
227 [Evaluation of the antiviral and cellular antireplication effect of human interferon on a line of primary hepatocarcinoma]. G Ital Chemioter 1986 0.75
228 [Acute respiratory infections caused by viruses, mycoplasmas, rickettsias and chlamydias with bronchial and pulmonary localization. 2 year's experience in the province of Ancona]. Minerva Med 1982 0.75
229 [The role of surgery in the treatment of primary carcinoma of the gallbladder. Review of 86 cases]. G Chir 1997 0.75
230 Effect of steroids and adenine-arabinoside (araA) on growth and HBsAg production of a human hepatoma cell line. Arch Virol 1983 0.75